Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE)
Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is an ADC targeting GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth and can be used in the research of hepatocellular carcinoma (HCC). MW :145.58 KD.
| Trivial name | GC33 |
| Catalog Number | D4061 |
| CAS# | 1365267-33-9 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/anti-gpc3-glypican-3-codrituzumab-mmae.html |